Hematopoietic Stem and Progenitor Cells

Genome Editing

Genome Editing of Hematopoietic Stem and Progenitor Cells

CRISPR-Cas9 genome editing of human hematopoietic stem and progenitor cells (HSPCs) has advanced our understanding of the mechanisms that regulate hematopoiesis and is contributing to the development of novel cellular therapies. However, genome editing of HSPCs can be challenging due to inefficient delivery and expression of the CRISPR-Cas9 components. Explore the protocols and resources below for support on how to perform high-efficiency genome editing of HSPCs in your own lab.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.